Mangalam Drugs & Organics Limited (BOM:532637)

India flag India · Delayed Price · Currency is INR
73.74
-5.46 (-6.89%)
At close: Aug 28, 2025
-6.89%
Market Cap1.17B
Revenue (ttm)2.98B
Net Income (ttm)-97.62M
Shares Out15.83M
EPS (ttm)-6.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume29,971
Average Volume7,269
Open78.57
Previous Close79.20
Day's Range72.62 - 82.30
52-Week Range65.50 - 142.40
Beta0.04
RSI36.63
Earnings DateAug 8, 2025

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers API products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, ... [Read more]

Industry Pharmaceutical Preparations
Founded 1972
Employees 432
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532637
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.